Media Contact:
Nalini Padmanabhan
ASHG Director of Communications and Marketing
301.634.7346
press@ashg.org

For Immediate Release
Wednesday, October 4, 2017
10:00 a.m. U.S. Eastern Time

ASHG 2017 Tipsheet: Cancer Genetics

WHEN: Tuesday through Saturday, Oct. 17-21, 2017

WHERE: American Society of Human Genetics 2017 Annual Meeting
Orange County Convention Center
9899 International Drive, Orlando, FL 32819

WHAT: Invited and platform (oral) sessions and other presentations of the latest research in cancer genetics:

Wednesday, Oct. 18, 9:00-10:30 a.m., Room 330A, South Building
Platform Session: Pleiotropism and Penetrance in Cancer-causing Genes
Moderators: Pengei Liu, Baylor College of Medicine; and Wenyi Wang, University of Texas

Wednesday, Oct. 18, 9:00-10:30 a.m., Room 330C, South Building
Platform Session: Landscape of Cancer: Bioinformatic Analyses
Moderators: Lisa Mirabello, National Cancer Institute; and Daniel Schaid, Mayo Clinic

Wednesday, Oct. 18, 11:00 a.m.-12:30 p.m., Room 220B, South Building
Platform Session: Screening Cancer Cohorts for Novel Germline Cancer Genes
Moderators: Matthew Bainbridge, Rady Children's Hospital; and Elaine Ostrander, NHGRI

Wednesday, Oct. 18, 11:00 a.m.-12:30 p.m., Room 220F, South Building
Platform Session: Cancer Genetic Testing: Approaches, Barriers, and Psychosocial Impact
Moderators: Jessica Everett, New York University Medical Center; and Kathleen Blazer, City of Hope Comprehensive Cancer Center

Thursday, Oct. 19, 9:00-10:30 a.m., Room 330C, South Building
Platform Session: Non-coding Variation and Epigenetic Effects in Cancer
Moderators: Liying Zhang, Memorial Sloan Kettering Cancer Center; and Dawei Li, University of Vermont

Thursday, Oct. 19, 11:00 a.m.-12:30 p.m., Room 230C, South Building
Platform Session: Defining High Risk in Cancer
Moderators: Nicola Camp, University of Utah; and Sylvia Casadei, University of Washington

Thursday, Oct. 19, 11:30-11:45 a.m., Room 320, South Building
Platform Presentation: Association of polygenic risk scores for multiple cancers in a phenome-wide study: Results from The Michigan Genomics Initiative
L.G. Fritsche, University of Michigan School of Public Health, et al

Thursday, Oct. 19, 4:15-6:15 p.m., Room 310A, South Building
Invited Session: Analysis of Cancer Genome Variation Using Long-read Sequencing
Moderators: Jeffrey Rosenfeld, Rutgers Cancer Institute; and Sara Goodwin, Cold Spring Harbor Laboratory

Friday, Oct. 20, 9:45-10:00 a.m., Room 330C, South Building
Platform Presentation: Identification of enhancer elements at multiple renal cancer susceptibility loci using a massively parallel reporter assay (MPRA)
L. Machado Colli, National Cancer Institute, et al

Friday, Oct. 20, 10:15-11:15 a.m., Room 330A, South Building
Platform Session: Clinical Genomics in Cancer
Moderators: Sunita Setlur, Brigham & Women's Hospital; and Robert Klein, Icahn School of Medicine Mount Sinai

Friday, Oct. 20, 2:30-4:30 p.m., Room 220F, South Building
Invited Session: Metabolomic Perspectives in a Genomic Era: Garrod's Inborn Errors and Warburg's Theory of Cancer
Moderator: Stephen H. Tsang, Columbia University Medical Center

Friday, Oct. 20, 4:00-4:30 p.m., Room 230C, South Building
Invited Presentation: Sex differences in cancer and the role of X/Y genes
A.A. Lane, Harvard Medical School, et al

Friday, Oct. 20, 5:30-5:50 p.m., South Hall B, South Building
Featured Plenary Abstract: The contribution of rare variants, polygenic risk, and novel candidate genes to the hereditary risk of breast cancer in a large cohort of breast cancer families
N. Li, Peter MacCallum Cancer Center, et al

Saturday, Oct. 21, 8:30-9:30 a.m., Room 220B, South Building
Platform Session: Functional Analyses of Cancer Genes
Moderators: Sean Tavtigian, Huntsman Cancer Institute; and Michael Dean, National Cancer Institute

Saturday, Oct. 21, 9:45-10:45 a.m., Room 230G, South Building
Platform Session: Novel Genetic and Environmental Contributions to Cancer Risk
Moderators: Bryony Thompson, University of Utah; and Aniko Sabo, Baylor College of Medicine

Saturday, Oct. 21, 11:20-11:40 a.m., South Hall B, South Building
Featured Plenary Abstract: Massively parallel reporter assays combined with cell-type specific expression quantitative trait loci profiling identified a functional melanoma risk variant in HIV-1 inhibitor gene, MX2
J. Choi, National Cancer Institute, et al

Ongoing: Posters Open for Viewing, Exhibit Hall, South Building
Topic: Cancer Genetics, Posters 594-845

* * *

About the American Society of Human Genetics (ASHG)

Founded in 1948, the American Society of Human Genetics is the primary professional membership organization for human genetics specialists worldwide. Its nearly 8,000 members include researchers, academicians, clinicians, laboratory practice professionals, genetic counselors, nurses, and others with an interest in human genetics. The Society serves scientists, health professionals, and the public by providing forums to: (1) share research results through the ASHG Annual Meeting and in The American Journal of Human Genetics; (2) advance genetic research by advocating for research support; (3) educate current and future genetics professionals, health care providers, advocates, policymakers, educators, students, and the public about all aspects of human genetics; and (4) promote genetic services and support responsible social and scientific policies. For more information, visit: http://www.ashg.org.

9650 Rockville Pike | Bethesda, MD 20814 | 301.634.7300 | society@ashg.org | www.ashg.org
Connect with ASHG on Twitter (@GeneticsSociety) | Facebook | LinkedIn